FDA.reportPublic FDA data

Pulmonary Hypertension tadalafil 20 MG Oral Tablet [Alyq]

RxCUI
2110455
RxNorm name
Pulmonary Hypertension tadalafil 20 MG Oral Tablet [Alyq]
Display name
Pulmonary Hypertension tadalafil 20 MG Oral Tablet [Alyq]
Full name
Pulmonary Hypertension tadalafil 20 MG Oral Tablet [Alyq]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ALYQTADALAFILTeva Pharmaceuticals, Inc.2faa7a55-3054-456b-8465-6ea6dc1c0aa92023-04-01Warnings, Adverse reactionsExact identifier
rxcui: 2110455

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2faa7a55-3054-456b-8465-6ea6dc1c0aa9ALYQ 20 MG Oral Tablet [PSN] · Pulmonary Hypertension tadalafil 20 MG Oral Tablet [Alyq] [SBD] · Alyq 20 MG Oral Tablet [SY] · Alyq 20 MG Pulmonary Hypertension Oral Tablet [SY]45These highlights do not include all the information needed to use ALYQ ® safely and effectively. See full prescribing information for ALYQ ® . ALYQ ® (tadalafil) tablets, for oral administration Initial U.S. Approval: 200320230401